{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:59:02Z","timestamp":1783479542127,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/sc.2015.195","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T10:21:49Z","timestamp":1445941309000},"page":"78-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Initial experience with the treatment of neurogenic detrusor overactivity with a new \u03b2-3 agonist (mirabegron) in patients with spinal cord injury"],"prefix":"10.1038","volume":"54","author":[{"given":"J","family":"W\u00f6llner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pannek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"BFsc2015195_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/B978-0-444-52901-5.00017-4","volume":"110","author":"JN Panicker","year":"2013","unstructured":"Panicker JN, De Seze M, Fowler CJ . Neurogenic lower urinary tract dysfunction. Handb Clin Neurology 2013; 110: 209\u2013220.","journal-title":"Handb Clin Neurology"},{"key":"BFsc2015195_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/0269215509353252","volume":"24","author":"JN Panicker","year":"2010","unstructured":"Panicker JN, de Seze M, Fowler CJ . Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. Clin rehabil 2010; 24: 579\u2013589.","journal-title":"Clin rehabil"},{"key":"BFsc2015195_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ucl.2010.07.004","volume":"37","author":"CJ Fowler","year":"2010","unstructured":"Fowler CJ, Dalton C, Panicker JN . Review of neurologic diseases for the urologist. Urol Clin North Am 2010; 37: 517\u2013526.","journal-title":"Urol Clin North Am"},{"key":"BFsc2015195_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2009.04.028","volume":"56","author":"M Stohrer","year":"2009","unstructured":"Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Europ Urol 2009; 56: 81\u201388.","journal-title":"Europ Urol"},{"key":"BFsc2015195_CR5","doi-asserted-by":"publisher","first-page":"e16718","DOI":"10.1371\/journal.pone.0016718","volume":"6","author":"TM Kessler","year":"2011","unstructured":"Kessler TM, Bachmann LM, Minder C, Lohrer D, Umbehr M, Schunemann HJ et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS ONE 2011; 6: e16718.","journal-title":"PLoS ONE"},{"key":"BFsc2015195_CR6","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s40265-014-0271-z","volume":"74","author":"M Sanford","year":"2014","unstructured":"Sanford M . OnabotulinumtoxinA (Botox((R))): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injury. Drugs 2014; 74: 1659\u20131672.","journal-title":"Drugs"},{"issue":"2","key":"BFsc2015195_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.eururo.2015.07.071","volume":"69","author":"Jan Groen","year":"2016","unstructured":"Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Europ Urol 2015 e-pub ahead of print 21 August 2015; doi: 10.1016\/j.eururo.2015.07.071.","journal-title":"European Urology"},{"key":"BFsc2015195_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/iju.12568","volume":"21","author":"CR Chapple","year":"2014","unstructured":"Chapple CR, Kaplan SA, Mitcheson D, Blauwet MB, Huang M, Siddiqui E et al. Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year. Int J Urol 2014; 21: 960\u2013967.","journal-title":"Int J Urol"},{"key":"BFsc2015195_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eururo.2014.06.052","volume":"67","author":"C Chapple","year":"2015","unstructured":"Chapple C, Khullar V, Nitti VW, Frankel J, Herschorn S, Kaper M et al. Efficacy of the beta3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Europ Urol 2015; 67: 11\u201314.","journal-title":"Europ Urol"},{"key":"BFsc2015195_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/nau.22505","volume":"33","author":"CR Chapple","year":"2014","unstructured":"Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC . Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn 2014; 33: 17\u201330.","journal-title":"Neurourol Urodyn"},{"key":"BFsc2015195_CR11","first-page":"7","volume":"61","author":"N Wada","year":"2015","unstructured":"Wada N, Okazaki S, Kobayashi S, Hashizume K, Kita M, Matsumoto S et al. Efficacy of combination therapy with mirabegron for anticholinergic-resistant neurogenic bladder: videourodynamic evaluation. Hinyokika Kiyo 2015; 61: 7\u201311.","journal-title":"Hinyokika Kiyo"},{"key":"BFsc2015195_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.urology.2015.01.002","volume":"85","author":"Y Matsukawa","year":"2015","unstructured":"Matsukawa Y, Takai S, Funahashi Y, Yamamoto T, Gotoh M . Urodynamic evaluation of the efficacy of mirabegron on storage and voiding functions in women with overactive bladder. Urology 2015; 85: 786\u2013790.","journal-title":"Urology"},{"key":"BFsc2015195_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/bju.13068","volume":"116","author":"O Yamaguchi","year":"2015","unstructured":"Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O et al. Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study). BJU Int 2015; 116: 612\u2013622.","journal-title":"BJU Int"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sc2015195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc2015195","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc2015195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:29:13Z","timestamp":1684621753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sc2015195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFsc2015195"],"URL":"https:\/\/doi.org\/10.1038\/sc.2015.195","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"assertion":[{"value":"8 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}